mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.28 |
0.01 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |